These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 11547357

  • 1. Measurement of hematological, clinical chemistry, and infection parameters from hirudinized blood collected in universal blood sampling tubes.
    Menssen HD, Brandt N, Leben R, Müller F, Thiel E, Melber K.
    Semin Thromb Hemost; 2001 Aug; 27(4):349-56. PubMed ID: 11547357
    [Abstract] [Full Text] [Related]

  • 2. The use of hirudin as universal anticoagulant in haematology, clinical chemistry and blood grouping.
    Menssen HD, Melber K, Brandt N, Thiel E.
    Clin Chem Lab Med; 2001 Dec; 39(12):1267-77. PubMed ID: 11798089
    [Abstract] [Full Text] [Related]

  • 3. In vitro studies on thrombin generation in citrated, r-hirudinized and heparinized whole blood.
    Kaiser B, Fareed J, Walenga JM, Hoppensteadt D, Markwardt F.
    Thromb Res; 1991 Dec 01; 64(5):589-96. PubMed ID: 1808763
    [Abstract] [Full Text] [Related]

  • 4. Effect of drawing a discard tube on PT and APTT results in healthy adults.
    Bamberg R, Cottle JN, Williams JC.
    Clin Lab Sci; 2003 Dec 01; 16(1):16-9. PubMed ID: 12587654
    [Abstract] [Full Text] [Related]

  • 5. Hirudin as alternative anticoagulant--a historical review.
    Markwardt F.
    Semin Thromb Hemost; 2002 Oct 01; 28(5):405-14. PubMed ID: 12420235
    [Abstract] [Full Text] [Related]

  • 6. Use of EDTA samples for prothrombin time measurement in patients receiving oral anticoagulants.
    Horsti J.
    Haematologica; 2001 Aug 01; 86(8):851-5. PubMed ID: 11522542
    [Abstract] [Full Text] [Related]

  • 7. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
    Flather MD, Weitz JI, Yusuf S, Pogue J, Sussex B, Campeau J, Gill J, Schuld R, Joyner CD, Morris AL, Lai C, Théroux P, Marquis JF, Chan YK, Venkatesh G, Jessel A.
    Eur Heart J; 2000 Sep 01; 21(17):1473-81. PubMed ID: 10952840
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The effect of specimen hemolysis on coagulation test results.
    Laga AC, Cheves TA, Sweeney JD.
    Am J Clin Pathol; 2006 Nov 01; 126(5):748-55. PubMed ID: 17050072
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Under-filled blood collection tubes containing K2EDTA as anticoagulant are acceptable for automated complete blood counts, white blood cell differential, and reticulocyte count.
    Xu M, Robbe VA, Jack RM, Rutledge JC.
    Int J Lab Hematol; 2010 Oct 01; 32(5):491-7. PubMed ID: 20041968
    [Abstract] [Full Text] [Related]

  • 12. Experimental studies on a recombinant hirudin, CGP 39393.
    Gray E, Watton J, Cesmeli S, Barrowcliffe TW, Thomas DP.
    Thromb Haemost; 1991 Apr 08; 65(4):355-9. PubMed ID: 2057916
    [Abstract] [Full Text] [Related]

  • 13. Effects of heparin and hirudin on thrombin generation and platelet aggregation after intrinsic activation of platelet rich plasma.
    Gallistl S, Muntean W, Leis HJ.
    Thromb Haemost; 1995 Oct 08; 74(4):1163-8. PubMed ID: 8560429
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics and pharmacodynamics of hirudin in man after single subcutaneous and intravenous bolus administration.
    Bichler J, Fichtl B, Siebeck M, Fritz H.
    Arzneimittelforschung; 1988 May 08; 38(5):704-10. PubMed ID: 3415713
    [Abstract] [Full Text] [Related]

  • 16. The comparative effects of recombinant hirudin (CGP 39393) and standard heparin on thrombus growth in rabbits.
    Agnelli G, Pascucci C, Cosmi B, Nenci GG.
    Thromb Haemost; 1990 Apr 12; 63(2):204-7. PubMed ID: 2363121
    [Abstract] [Full Text] [Related]

  • 17. Pharmacology of recombinant hirudin.
    Nowak G.
    Semin Thromb Hemost; 2002 Oct 12; 28(5):415-24. PubMed ID: 12420236
    [Abstract] [Full Text] [Related]

  • 18. Hematology tests of blood anticoagulated with magnesium sulphate.
    Kondo H, Kobayashi E, Itani T, Tatsumi N, Tsuda I.
    Southeast Asian J Trop Med Public Health; 2002 Oct 12; 33 Suppl 2():6-9. PubMed ID: 12755260
    [Abstract] [Full Text] [Related]

  • 19. Markers of hemostatic system activation during thromboprophylaxis with recombinant hirudin in total hip replacement.
    Cofrancesco E, Cortellaro M, Leonardi P, Corradi A, Ravasi F, Bertocchi F.
    Thromb Haemost; 1996 Mar 12; 75(3):407-11. PubMed ID: 8701398
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.